Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3687)
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
1,236
Price
$23.39
Total Value
$28.91K
Shares Held After
17,795
% of Holdings
6.5%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
7,455
Price
$23.39
Total Value
$174.37K
Shares Held After
74,266
% of Holdings
9.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
100
Price
$100.85
Total Value
$10.09K
Shares Held After
120,058
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
400
Price
$99.44
Total Value
$39.77K
Shares Held After
120,158
% of Holdings
0.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
2,266
Price
$98.37
Total Value
$222.91K
Shares Held After
120,558
% of Holdings
1.8%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
241
Price
$18.00
Total Value
$4.34K
Shares Held After
351,370
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
466
Price
$460.43
Total Value
$214.56K
Shares Held After
51,436
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,151,458
Price
$0.68
Total Value
$1.46M
Shares Held After
2,651,817
% of Holdings
44.8%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
1,905,115
Price
$0.68
Total Value
$1.30M
Shares Held After
2,348,183
% of Holdings
44.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
3,961
Price
$73.25
Total Value
$290.15K
Shares Held After
4,478,447
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,404
Price
$72.65
Total Value
$319.94K
Shares Held After
4,482,408
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
3,775
Price
$71.46
Total Value
$269.75K
Shares Held After
4,486,812
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,860
Price
$70.70
Total Value
$555.71K
Shares Held After
4,490,587
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
3,994
Price
$73.25
Total Value
$292.57K
Shares Held After
675,686
% of Holdings
0.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,484
Price
$72.64
Total Value
$325.70K
Shares Held After
679,680
% of Holdings
0.7%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
3,716
Price
$71.44
Total Value
$265.48K
Shares Held After
684,164
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,806
Price
$70.69
Total Value
$551.80K
Shares Held After
687,880
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
1,376
Price
$460.43
Total Value
$633.55K
Shares Held After
10,127
% of Holdings
12.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
1,751
Price
$460.43
Total Value
$806.21K
Shares Held After
22,046
% of Holdings
7.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
1,925
Price
$460.43
Total Value
$886.33K
Shares Held After
20,819
% of Holdings
8.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
2,021
Price
$460.43
Total Value
$930.53K
Shares Held After
12,914
% of Holdings
13.5%
Tectonic Therapeutic, Inc. (TECX)
REICIN ALISE — Director
Shares
2,500
Price
$21.10
Total Value
$52.75K
Shares Held After
237,547
% of Holdings
1.1%
Ernexa Therapeutics Inc. (ERNA)
Cherington Charles — 10% Owner
Shares
4,000,000
Price
$0.50
Total Value
$2.00M
Shares Held After
6,779,440
% of Holdings
59.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
100
Price
$104.76
Total Value
$10.48K
Shares Held After
122,824
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
700
Price
$103.68
Total Value
$72.57K
Shares Held After
122,924
% of Holdings
0.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,913
Price
$102.66
Total Value
$196.38K
Shares Held After
123,624
% of Holdings
1.5%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
521,739
Price
$5.75
Total Value
$3.00M
Shares Held After
11,931,839
% of Holdings
4.4%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
6,622
Price
$18.12
Total Value
$119.99K
Shares Held After
351,611
% of Holdings
1.8%
MapLight Therapeutics, Inc. (MPLT)
Garnett Timothy John — Director
Shares
14,124
Price
$17.89
Total Value
$252.68K
Shares Held After
14,124
% of Holdings
100.0%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
182,295
Price
$0.82
Total Value
$148.77K
Shares Held After
4,803,275
% of Holdings
3.7%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
161,422
Price
$0.82
Total Value
$131.74K
Shares Held After
4,253,298
% of Holdings
3.7%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
110
Price
$45.00
Total Value
$4.95K
Shares Held After
12,546
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,960
Price
$72.27
Total Value
$430.75K
Shares Held After
4,498,447
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,040
Price
$71.80
Total Value
$1.01M
Shares Held After
4,504,407
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,799
Price
$72.28
Total Value
$419.17K
Shares Held After
695,686
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,201
Price
$71.80
Total Value
$1.02M
Shares Held After
701,485
% of Holdings
2.0%
Sagimet Biosciences Inc. (SGMT)
Rozek Elizabeth — Chief Legal & Admin. Officer
Shares
2,622
Price
$5.36
Total Value
$14.05K
Shares Held After
190,959
% of Holdings
1.4%
Sagimet Biosciences Inc. (SGMT)
Martins Eduardo Bruno — Chief Medical Officer
Shares
3,640
Price
$5.36
Total Value
$19.51K
Shares Held After
103,296
% of Holdings
3.4%
Sagimet Biosciences Inc. (SGMT)
Chauche Thierry — Chief Financial Officer
Shares
1,312
Price
$5.36
Total Value
$7.03K
Shares Held After
15,688
% of Holdings
7.7%
Sagimet Biosciences Inc. (SGMT)
Happel David — Director
Shares
12,101
Price
$5.36
Total Value
$64.86K
Shares Held After
677,621
% of Holdings
1.8%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
2,434
Price
$10.27
Total Value
$25.00K
Shares Held After
582,072
% of Holdings
0.4%
Lyell Immunopharma, Inc. (LYEL)
Bulis Veronica Sanchez — VP, Corporate Controller
Shares
254
Price
$23.12
Total Value
$5.87K
Shares Held After
15,637
% of Holdings
1.6%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
147
Price
$23.12
Total Value
$3.40K
Shares Held After
18,609
% of Holdings
0.8%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
109
Price
$23.12
Total Value
$2.52K
Shares Held After
19,031
% of Holdings
0.6%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
438
Price
$23.12
Total Value
$10.13K
Shares Held After
81,721
% of Holdings
0.5%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
590
Price
$14.11
Total Value
$8.32K
Shares Held After
58,052
% of Holdings
1.0%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
589
Price
$13.65
Total Value
$8.04K
Shares Held After
58,642
% of Holdings
1.0%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
441
Price
$14.11
Total Value
$6.22K
Shares Held After
59,574
% of Holdings
0.7%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
440
Price
$13.65
Total Value
$6.01K
Shares Held After
60,015
% of Holdings
0.7%
Tectonic Therapeutic, Inc. (TECX)
Lochner Daniel — Chief Financial Officer
Shares
6,000
Price
$21.61
Total Value
$129.66K
Shares Held After
32,044
% of Holdings
18.7%
Showing 2251–2300 of 3687 transactions (page 46 of 74)